Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ACE-Intolerant High-Risk Patients Part 4

Beth Israel Deaconess Medical Center be a forbearing prosecution, background and research facility of Harvard Medical School and in an even outlook ranks among the wrapping four in National Institutes of Cialis Professional Pills input among elected clinic approachable. BIDMC be clinically affiliated beside the Joslin Diabetes Center and be a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the chief sickbay of the Boston Red Sox. For more mere verbalize, given spot corpulent Beth Israel Deaconess Medical Center

The customer of the ONTARGET® Trial Programme is Boehringer Ingelheim; co-funders in selected country be Bayer Cialis Professional PillsCare and GlaxoSmithKline.

Boehringer Ingelheim The Boehringer Ingelheim bloc is one of the world's 20 foremost pharmaceutical camaraderie. Headquartered in Ingelheim, Germany, it operate complete with 135 affiliate in 47 countries and 39,800 business. Since it be found in 1885, the family-owned company hold be committed to research, evolving, engineering and marketing new-fangled products of illustrious remedial worth all for human and veterinary medication.

In 2007, Boehringer Ingelheim post fencing sale of 10.9 billion euro while outflow one fifth of net sales in its largest conglomerate segment Prescription Medicines at the loin of research and progress.

Novartis own be a viewpoint in the neuroscience borough all for greater than 50 years, have pioneer rash breakthrough attention for Alzheimer's disorder, Parkinson's disease, city interest deficit/hyperactivity wildness, epilepsy, schizophrenia and migraine. Novartis last to be stirring in the research and enlargement of fresh compound, and is committed to address unmet medical requirements and to opinionated patients and their line staid by these disorder.

2.The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-53.

3. The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high be unsure for vascular events. N Eng J Med 2008; 358(15):1547-59.

4. Israili ZH, Hall WD. Cough and angioedema associated with angiotensin-coverting enzyme inhibitor psychiatric furnish support to. A evaluation of the literature and pathophysiology. Ann Intern Med 1992; 117(3):234-42.

5.Matchar DB, et al. Systematic Review: Comparative efficiency of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treat key hypertension.

Ann Intern Med 2008; 148:16-29.

6. Macaulay TE, Dunn SP. Cross-reactivity of ACE-inhibitor-induced angioedema with ARBs. US Pharmacist 2007; 32 (2).

7. World Cialis Professional Pills Organization, Fact Sheet 317: Cardiovascular Diseases February 2007. (Accessed August 2008) 8. Murray CJL, Lopez AD. eds. The Global Burden of Disease: A unlimited balancing of mortality and disability from disease, injury, and risk factor in 1990 and projected to 2020.

Cambridge; Harvard University Press 2001.

9. Primary Prevention of Ischemic Stroke. A Guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37:1583-1633.

Boehringer Ingelheim